BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12778818)

  • 1. [The prognostic relation of nm23-H1/NDPK-A with leukemia and lymphoma].
    Li HY; Liu JS; Wang YF
    Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):74-7. PubMed ID: 12778818
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum levels of mm23-H1 protein and their clinical implications in malignant lymphoma].
    Niitsu N
    Rinsho Ketsueki; 2001 Dec; 42(12):1155-61. PubMed ID: 11828717
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
    Okabe-Kado J
    Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of biological prognostic factors in non-Hodgkin lymphoma: analysis of serum and cell surface nm 23-H1 protein].
    Niitsu N
    Rinsho Ketsueki; 2003 Apr; 44(4):211-8. PubMed ID: 12784653
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphoma.
    Niitsu N; Okamoto M; Honma Y; Nakamine H; Tamaru JI; Nakamura S; Yoshino T; Higashihara M; Hirano M; Okabe-Kado J;
    Leukemia; 2003 May; 17(5):987-90. PubMed ID: 12750720
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
    Niitsu N; Okabe-Kado J; Okamoto M; Takagi T; Yoshida T; Aoki S; Hirano M; Honma Y
    Blood; 2001 Mar; 97(5):1202-10. PubMed ID: 11222361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overexpression of differentiation inhibitory factor/nm23 in acute myeloid leukemia].
    Kado J; Yokoyama A
    Rinsho Ketsueki; 1998 Feb; 39(2):92-4. PubMed ID: 9545807
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
    Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
    Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
    Blood; 1999 Nov; 94(10):3541-50. PubMed ID: 10552965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma.
    Niitsu N; Okamoto M; Okabe-Kado J; Takagi T; Yoshida T; Aoki S; Honma Y; Hirano M
    Leukemia; 2001 May; 15(5):832-9. PubMed ID: 11368446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
    Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
    Blood; 2000 Aug; 96(3):1080-6. PubMed ID: 10910925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome.
    Ito Y; Okabe-Kado J; Honma Y; Iwase O; Shimamoto T; Ohyashiki JH; Ohyashiki K
    Leukemia; 2002 Feb; 16(2):165-9. PubMed ID: 11840281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. nm23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia.
    Koomägi R; Sauerbrey A; Zintl F; Volm M
    Anticancer Res; 1998; 18(6A):4307-9. PubMed ID: 9891483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. nm23: unraveling its biological function in cell differentiation.
    Lombardi D; Lacombe ML; Paggi MG
    J Cell Physiol; 2000 Feb; 182(2):144-9. PubMed ID: 10623877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.
    Aryee DN; Simonitsch I; Mosberger I; Kos K; Mann G; Schlögl E; Pötschger U; Gadner H; Radaszkiewicz T; Kovar H
    Br J Cancer; 1996 Dec; 74(11):1693-8. PubMed ID: 8956779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of nm23/nucleoside diphosphate kinase by casein kinase 2 in vitro.
    Engel M; Issinger OG; Lascu I; Seib T; Dooley S; Zang KD; Welter C
    Biochem Biophys Res Commun; 1994 Mar; 199(2):1041-8. PubMed ID: 8135777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NM23 expression as prognostic factor in colorectal carcinoma.
    Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Soda G; Bosco D; Bezzi M; Vietri F; Beltrami V
    G Chir; 2002 Mar; 23(3):61-3. PubMed ID: 12109225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly.
    Palacios F; Schweitzer JK; Boshans RL; D'Souza-Schorey C
    Nat Cell Biol; 2002 Dec; 4(12):929-36. PubMed ID: 12447393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of nucleoside diphosphate kinases (NDPK/NM23) during Xenopus early development.
    Ouatas T; Sélo M; Sadji Z; Hourdry J; Denis H; Mazabraud A
    Int J Dev Biol; 1998 Jan; 42(1):43-52. PubMed ID: 9496785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation.
    Willems R; Van Bockstaele DR; Lardon F; Lenjou M; Nijs G; Snoeck HW; Berneman ZN; Slegers H
    J Biol Chem; 1998 May; 273(22):13663-8. PubMed ID: 9593706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.